Actions Panel
CV Risk Reduction in Diabetes (SGLT2i/GLP-1 RA and CVD) - June 3, 2020
By CHEP+
When and where
Date and time
Location
Online 1929 Bayview Ave. Toronto, Ontario M4G3E8 Canada
Map and directions
How to get there
Description
Upcoming CPD Sessions
CV Risk Reduction in Diabetes (SGLT2 inhibitors/GLP-1 Receptor Agonists in Patients with DM and CVD)
June 3, 2020 • 7-9PM Eastern Time
Speaker Dr. Richard Choi, moderator Dr. Sheldon Tobe
Upon completion of this activity, participants should be able to:
- Describe the patient who should be treated with an SGLT2i or GLP-1 RA.
- Explain the rational for this treatment and the potential benefits.
- Describe the steps for initiating and monitoring therapy for patients with diabetes.
Accredited for 3 credits per hour, total of maximum 6 credits.
FAQs
• How can I contact the organizer with any questions?
To contact the organizer, email: Diane Hua-Stewart at diane.hua@sunnybrook.ca.
• To learn more:
Please visit the event website: https://www.cchangeguidelines.com/